Primary hyperoxaluria

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

6 events
Jun 2025Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)

Arbor Biotechnologies — PHASE1, PHASE2

TrialRECRUITING
Feb 2025Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)

Guangzhou Women and Children's Medical Center — EARLY_PHASE1

TrialACTIVE NOT RECRUITING
Jul 2024Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)

RenJi Hospital — EARLY_PHASE1

TrialRECRUITING
Jan 2023Retrospective and Prospective Follow-up of Patients With Primary Hyperoxaluria Type 1 Treated With Lumasiran in France.

Hospices Civils de Lyon

TrialRECRUITING
Dec 2021BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)

Alnylam Pharmaceuticals

TrialACTIVE NOT RECRUITING
Apr 2021Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

Dicerna Pharmaceuticals, Inc., a Novo Nordisk company — PHASE2

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Primary hyperoxaluria.
Check the disease page for updates →

Clinical Trial Landscape

6 active trials
1Phase 2
2Unknown
1PHASE1, PHASE2
2EARLY_PHASE1
6Total recruiting
Search clinical trials for Primary hyperoxaluria

Recent News & Research

No recent news articles indexed yet for Primary hyperoxaluria.
Search PubMed for Primary hyperoxaluria

Browse all Primary hyperoxaluria news →

Specialist Network

Top 6 by expertise

View all Primary hyperoxaluria specialists →

Quick Actions